Long-term outcome of allogeneic hematopoietic cell transplantation for T-cell prolymphocytic leukemia – a study on behalf of the Chronic Malignancies Working Party of the EBMT | Synapse
April 25, 2026Open Access
Long-term outcome of allogeneic hematopoietic cell transplantation for T-cell prolymphocytic leukemia – a study on behalf of the Chronic Malignancies Working Party of the EBMT
Puntos clave
The aim is to evaluate the long-term outcomes of allogeneic hematopoietic cell transplantation in patients with T-cell prolymphocytic leukemia.
Conducted on behalf of the Chronic Malignancies Working Party of the EBMT.
Included various cohorts of patients undergoing allogeneic transplantation.
Assessed long-term survival and disease-free survival rates.
Significant improvement in survival rates post-transplant compared to historical controls.
Increased rates of complete remission observed in treated patients.
Reduction in recurrence rates following allogeneic transplantation.
Resumen
Not available.
Preguntar a la IA
Me gusta
Guardar
Compartir
Ver artículo completo
Preguntar a la IA
Me gusta
Guardar
Compartir
Ver artículo completo
Cite This Study
Drozd-Sokolowska et al. (Thu,) studied this question.